SALT LAKE CITY, Feb. 22 (HSMN NewsFeed) — Amedica Corporation (AC), a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today an agreement with Orthopaedic Synergy, Inc. (OSI), …
Devices, Orthopaedic
Amedica Corp, Orthopaedic Synergy, OMNIlife Science, Enztec
Posts from ‘February, 2010’
Amedica(R) Signs Joint Venture Agreement With Orthopaedic Synergy(R)
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Phase 2 Extension Study Demonstrated Sustained Weight Loss SAN DIEGO and OSAKA, Japan, Feb. 22, 2010 (HSMN NewsFeed) — Amylin Pharmaceuticals, Inc. (Nasdaq:AMLN ) and Takeda Pharma Company Limited (TSE:4502.to ) announced today that the compa…
Biopharmaceuticals
Amylin Pharmaceuticals, Takeda Laboratory, pramlintide, metreleptin
Enzon Board of Directors Appoints Executive Committee
Jeffrey Buchalter Steps Down as CEO of Enzon BRIDGEWATER, N.J.–(HSMN NewsFeed)–Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN ) today announced that Jeffrey Buchalter has resigned as Chief Executive Officer and Director of Enzon, effective immediately, and…
Biopharmaceuticals, Personnel
Enzon Pharmaceuticals
QLT Names Joseph L. Turner to the Board of Directors
VANCOUVER, British Columbia, Feb. 22, –(HSMN NewsFeed)– QLT Inc. (Nasdaq:QLTI ) (TSX:QLT ) ("QLT" or the "Company") today announced the appointment of Mr. Joseph L. Turner to the Company’s Board of Directors and Audit and Risk Committ…
Biopharmaceuticals, Personnel
QLT
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
THOUSAND OAKS, Calif., Feb. 19 (HSMN NewsFeed) — Amgen Inc. (Nasdaq:AMGN ) today announced that the U.S. Food and Drug Administration (FDA) has evaluated the content of the Company’s Complete Response submission for Prolia(TM) (denosumab) in the treatme…
Biopharmaceuticals, FDA
Amgen, Prolia, denosumab, osteoporosis
Ethicon Endo-Surgery Announces Agreement with Hologic Inc. To Resolve Patent Disputes
CINCINNATI, Feb. Nineteen (HSMN NewsFeed) — Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, announced today that it has reached an agreement with Hologic, Inc., and Hologic subsidiary Suros Surgical Systems, Inc., settling litigation in Ohio and dism…
Devices, Surgery, Litigation
Ethicon Endo-Surgery, Hologic, Suros Surgical Systems, MAMMOTOME
Hologic Announces Settlement In Patent Infringement Suits
BEDFORD, Mass., Feb. 19 (HSMN NewsFeed) — Hologic, Inc. (Hologic or the Company) (Nasdaq:HOLX ), a big developer, manufacturer and supplier of premium diagnostics, pathology imaging systems and surgical products dedicated to serving the healthcare nee…
Devices, Surgery, Litigation
Hologic, Ethicon Endo-Surgery, Suros Surgical Systems, MAMMOTOME
Tryton Stent Implanted in First Cases in Portugal and Austria
Company Celebrates 750th Implant DURHAM, N.C.–(HSMN NewsFeed)–Tryton Pharmaceutical, Inc., the top developer of stents designed to definitively treat bifurcation lesions, today announced that the Tryton® stent has been implanted for the first time in…
Devices, Interventional Cardiology
Tryton Pathology, bifurcation lesions, Side Branch Stent
BSD Clinical Announces First Swiss Installation of the BSD-2000/3D Hyperthermia System at Kantonsspital Aarau
SALT LAKE CITY–(HSMN NewsFeed)–BSD Clinical Corporation (NASDAQ: BSDM ) announces the installation of the advanced BSD-2000/3D Hyperthermia System at the Department of Radiation Oncology of Kantonsspital Aarau (KSA), Aarau, Switzerland. The BSD-2000/3D at…
Devices, Oncology
BSD Clinical, BSD-2000/3D, Hyperthermia System
Derma Sciences Signs Contract With Major Wound Care Company for Exclusive Distribution of BIOGUARD(TM) Barrier Dressings
Medline Industries gains exclusivity on sales of BIOGUARD into Acute Care PRINCETON, N.J., Feb. 18 (HSMN NewsFeed) — Derma Sciences, Inc. (Nasdaq:DSCI ), a specialty medical device and medical company focused on advanced wound care, today anno…
Devices, Wound Care, Distribution
Derma Sciences, Medline, Quick-Med Technologies,BIOGUARD

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.